Looking For Ebola Virus Meds? WHO Recommends These Two Antibody Treatments
The World Health Organization (WHO) has published its first guideline for Ebola virus disease therapeutics, with new recommendations for using…
Testosterone-Drug Focused Penny Stock Falls On Bankruptcy Fears
Clarus Therapeutics Holdings Inc (NASDAQ:CRXT) has implemented a 40% reduction in staff as it evaluates strategic alternatives and terminates certain research…
Bavarian Nordic Recruits US Firm For Packaging Services For Its Monkeypox Vaccine
Bavarian Nordic A/S (OTC:BVNRY) signed up a U.S.-based manufacturer to fill and finish its Jynneos monkeypox vaccine, and the production is…
Axsome’s Depression Candidate Scores FDA Nod, Stock Surges To 52-High
The FDA has approved Axsome Therapeutics Inc’s (NASDAQ:AXSM) Auvelity (dextromethorphan HBr -bupropion HCl) extended-release tablets for major depressive disorder (MDD) in…
Read Why Aeglea BioTherapeutics Shares Are Skyrocketing Today?
The European Medicines Agency (EMA) has validated Aeglea BioTherapeutics Inc’s (NASDAQ:AGLE) marketing application seeking approval for pegzilarginase for the treatment of…
Caribou’s Blood Cancer Candidate Shows Response Rates Better Than Novartis,’ This Analyst Writes
Last week, Caribou Biosciences Inc (NASDAQ:CRBU) announced Q2 earnings and provided updated results from the Phase 1 ANTLER trial of the company’s…
Blueprint Medicines’ Ayvakit ‘Will Garner Approval’ Despite Questions, This Analyst Says
HC Wainwright has cut the price target on Blueprint Medicines Corporation (NASDAQ:BPMC) from $100 to $80 and reiterated the Buy rating. The analyst…
Analysts Are Bullish On 89bio’s NASH Data Slated For Early Next Year
Earlier today, 89bio Inc (NASDAQ:ETNB) concluded enrollment in ENLIVEN Phase 2b trial of pegozafermin for non-alcoholic steatohepatitis (NASH), enabling topline results in…
Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment
Top Biden administration officials are poised to lay out new steps to accelerate the U.S. response amid the spread of monkeypox and demand for vaccines & treatments.
Bayer, Exscientia Part Ways On Artificial Intelligence Collaboration
Exscientia Plc (NASDAQ:EXAI) has ended its collaboration with Bayer AG (OTC: BAYRY) following the achievement of a drug discovery milestone. Exscientia will retain the…